|
HS Code |
178376 |
| Product Name | Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate |
| Cas Number | 180274-14-8 |
| Molecular Formula | C8H5ClF3N2O2 |
| Molecular Weight | 252.59 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Melting Point | 53-56°C |
| Boiling Point | No data available |
| Solubility | Soluble in organic solvents such as DMSO and DMF |
| Smiles | CCOC(=O)C1=CN=C(N=C1Cl)C(F)(F)F |
| Inchi | InChI=1S/C8H5ClF3N2O2/c1-2-16-7(15)4-3-13-8(12,6(4)9)14-5(10)11/h3H,2H2,1H3 |
| Storage Temperature | Store at 2-8°C |
| Synonyms | Ethyl 4-chloro-2-(trifluoromethyl)pyrimidine-5-carboxylate |
As an accredited Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate, 25 grams, supplied in a sealed amber glass bottle with tamper-evident cap. |
| Shipping | Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate is shipped in secure, leak-proof containers compliant with chemical transport regulations. Packaging ensures protection from moisture and light. The product is clearly labeled and accompanied by a Safety Data Sheet (SDS). Temperature and handling guidelines are strictly followed to maintain product integrity during transit. |
| Storage | **Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate** should be stored in a tightly sealed container, kept in a cool, dry, and well-ventilated area, away from sources of ignition and incompatible substances. Protect from moisture, extreme temperatures, and direct sunlight. Ensure proper chemical labeling, and store away from acids, bases, and strong oxidizing agents. Follow all relevant safety and chemical handling guidelines. |
Applications of Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate in Industrial ManufacturingOur plant produces Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate as a specialty intermediate for the synthesis of advanced chemicals. Below, we detail verified downstream applications within pharmaceutical APIs, agrochemicals, specialty polymers, and veterinary API production, highlighting industrial deployment and technical standards. 1. Pharmaceutical API Intermediate for Anti-Viral Drug SynthesisAPI manufacturers employ this pyrimidine carboxylate as a core building block in anti-viral compound synthesis, targeting nucleoside analogues and non-nucleoside inhibitors. The raw material enters the nucleophilic substitution and ester hydrolysis steps, yielding pyrimidine-based scaffolds with targeted substitution patterns. Material traceability and residual impurity control remain a regulatory focus throughout process validation and product release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Precursor in Agrochemical Active Ingredient ManufacturingMajor agrochemical producers integrate this pyrimidine derivative to build herbicide and fungicide actives with electron-withdrawing substituents for broad-spectrum field efficacy. Its regulated use underlies several patent-protected active molecules, requiring precise control over isomeric purity and residual solvent levels in production campaigns. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Specialty Fluorinated Polymer AdditivesPolymer chemical manufacturers deploy this raw material to introduce site-specific fluorine and chlorine substituents in functional monomers used in high-performance engineering plastics. The unique structure supports custom end-use properties, such as chemical resistance and flame retardance. Validated campaigns focus on secure handling, closed-system reactivity, and precise control of conversion ratios to minimize waste and off-specification output. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Starting Material in Veterinary Pharmaceutical SynthesisVeterinary pharmaceutical companies select this compound for the targeted synthesis of fluorinated pyrimidine analogues as API scaffolds in animal health products. Its consistent supply supports scale-up of multi-step routes, with a strong emphasis on impurity tracking and batch consistency to meet regulatory registration for finished veterinary medicines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Standing in the production facility, surrounded by the buzz of filtration systems and the faint scent of solvent, you start seeing chemistries not as abstract formulas, but as tangible, sometimes stubborn, realities. Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate isn’t just a name on a drum to us; it’s a result of thousands of test hours, process runs, and hands-on troubleshooting. While the structure hints at its reactive versatility, the features that matter most—purity, consistency, and reproducibility—come from engineering discipline, not lab-talk promises.
We produce Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate, commonly referenced by its working abbreviation during production, as a pale solid—sometimes a fine powder, sometimes a slightly clumped mass, depending on recent environmental humidity or transport conditions. Our batches typically register above 98% assay by HPLC, with single-digit ppm impurities, because even a small deviation triggers process investigation and rework. Loss-on-drying values range 0.3–0.8%, as trace moisture likes to hide between crystals, and every gram requires drying time and energy. Precise melting points fall between 90–92°C, although operators keep one eye on the temperature probe and one on the formation of the melt for early signs of byproduct contamination.
This product leaves the factory in various packaging sizes, matched with user feedback—5 kg poly drums for contract synthesis partners, and 500 g sealed bags for in-house R&D. We never pad shipments with nondescript fillers, because trace residues from lining materials can complicate downstream reactivity, wasted more than one batch for a partner in the past.
Our teams hear from downstream chemists regularly: demands for newer pyrimidine cores haven’t slowed. Pharmaceutical intermediates remain the dominant domain for Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate, especially in fluoroalkylated libraries where both the electron-deficient ring and the ethyl carboxylate allow for a diverse series of transformations. We see it used most frequently in nucleophilic substitution reactions, Suzuki couplings, and as a core building block for ligands where sterics and electronics both run the show. In contrast to methyl analogs, the ethyl group brings slightly slower hydrolysis—a benefit for stepwise synthesis where premature cleavage is a recipe for extra purification runs.
Crop science and specialty materials also echo similar needs: this compound feeds into heterocycle-rich scaffolds for agrochemicals, where both the trifluoromethyl and chloro substituents tweak membrane permeability and metabolic stability. We rarely see requests from flavor or fragrance applications, as the structure’s inherent bitterness and stability keep it away from consumables, but advanced material start-ups periodically grab a batch, especially for high-performance polymer modification, where electron-rich and electron-withdrawing features need to coexist.
The market groans under many pyrimidine derivatives. Still, minute, practiced differences from the wet bench set our product apart from generic alternatives. The isolated yield for this compound depends heavily on careful management of intermediates—chlorination runs cleaner with tailored base concentrations, while the trifluoromethyl addition stage wastes feedstock if reactor temperature bumps up uncontrolled. Our operators have learned that rapid changes in batch volumes can result in sudden changes in physical form, throwing filtration and crystallization time off by hours. Over the years, tweaks to solvent blend and temperature ramp-up have delivered a more filterable cake, not a sticky mess that fouls the tray dryer.
Compared to 4-methyl or 4-phenyl pyrimidines, the combined electron-withdrawing group arrangement in the 4-chloro-2-trifluoromethyl motif gives higher chemical stability and unique reactivity with nucleophiles, especially where selective mono-substitution matters. Ever since one customer switched from a bromo to a chloro leaving group, their process lost the excessive side reactions that had kept product yields unpredictable. On our side, this means tighter impurity control, but smoother feedback loops with partners who track mass balance as closely as we do.
Dry, stable, and pure aren’t marketing words—they’re ongoing struggles. Our production staff has spent late nights tracing the root cause of haze in solution, only to pinpoint a slightly off-pH final wash water. Each time a filtration slows unexpectedly, hands-on experience allows operators to anticipate blockages and fine-tune pressure settings without causing filter rupture and valuable product loss. Over the years, we built custom cleaning procedures for shared equipment, after cross-contamination from a sulfur-containing process threatened to set off costly recalls, teaching us to treat each step—crystallization, collection, drying—as both an art and a risk.
Repacking can stress sensitive compounds. We rely on quality nitrogen flushing and double-sealed liners to resist atmospheric moisture intake, a non-negotiable lesson ever since a poorly packed sample from years past clumped into a solid brick after a few humid days. Our specification, based on actual performance data and process trial records, keeps moisture limits below thresholds that have caused dissolution issues in fast-moving reaction lines.
As upstream manufacturers, we constantly compare our product with competitive structures. Simple 2,4-dichloropyrimidine, for instance, can serve as a base for similar reactions, but fails to offer the fine-tuned balance of reactivity and selectivity, since both halides can depart under similar conditions. The presence of the trifluoromethyl group here increases electrophilicity on the pyrimidine, but retains enough selectivity for substitution at the chloro position, facilitating orthogonal chemistries not as easily accessed with simpler analogs.
Customers sometimes ask whether alternate carboxylate esters would suit their project. We run parallel batches with methyl or isopropyl esters on occasion, and the ethyl ester finds a middle ground: less prone to hydrolytic cleavage than methyl, but more manageable in solvents and volatility than bulkier groups. This subtle control over downstream process rates has proven critical for larger scale partners plagued by premature hydrolysis or difficult solvent switching.
Feedback from the field guides more process adjustments than any internal spec document. A major European pharma group reported batch variability after switching suppliers, citing downstream chromatogram peaks never seen in our lots. Our investigation, aided by in-line GC-MS runs from the factory floor, traced these unknowns back to route differences—rival firms’ favor for less costly starting material yielded more oligomeric byproducts. By maintaining higher pressure and slower addition rates in key steps, our workflow keeps side-reaction formation below problematic thresholds. Over a hundred internal process records stretch back to our earliest scale-up runs, capturing tweaks made after every odd impurity spike, filter blockage, or crystallization miss. These working journals are as much a part of the product as the stacked cases of output readied for shipping.
The pressure from pharmaceutical partners and regulatory authorities never eases—our lot records confirm full traceability, batch archival, and up-to-date stability witnessing. REACH, and similar statutes elsewhere, require us to document not just the finished compound but every input and every phase transfer solvent traced through GMP guidelines. We established segregated process areas for halide intermediates, minimizing cross-contamination and confirming through frequent swab tests and batch tracking. A contamination scare or batch recall isn’t just paperwork; it’s long hours, delayed deliveries, and the ultimate test of a manufacturer’s commitment to doing work the hard way when shortcuts seem tempting.
Waste handling forms another pressure point. This product’s mother liquors contain fluorinated and chlorinated waste, which we neutralize and treat in closed-loop solvent recovery systems. We track each kilogram back to waste manifests, both for compliance, and for environmental stewardship. Reduction in mother liquor volume meant redesigning the solvent recovery stage—no one likes extra paperwork, but everybody loves avoiding costly external incineration fees. Shipping complies with international transport safety standards, but batch-level purity remains paramount, because partners stake whole drug or material development programs on reliable supply, not just regulatory checkboxes.
New team members often find the simplest steps—filter, dry, pack—end up filled with complexity. Over-dried product picks up static electricity, producing floating powder during packing that’s both a handling challenge and a waste of time reclaiming. If the filtered cake is too damp, it won’t pack efficiently, raising transport costs for water weight. Most line operators have learned to personally verify final dryness more with fingertips and the scale than by instrument readings alone, catching subtle shifts in feel and weight before any digital gauge gives notice. Interventions here sharpen final product quality more effectively than the crosstalk between lab technicians and process managers.
Collaboration with end-users stretches beyond technical datasheets and certificates. Our plant supervisors often participate in root-cause reviews when a customer reports batch reactivity issues, helping trace the problem back to environmental storage shifts, solvent mixing orders, or impurity migration from poorly controlled supply chains. In one notable instance, identifying an unknown peak in a customer’s chromatogram led us to run parallel stability trials under higher humidity storage, isolating the culprit as a trace decomposition product. Rather than offering apologies, we worked with the customer to deliver custom packaging and improved desiccation, helping maintain reactivity in their specific synthesis conditions. This type of hands-on, feedback-driven adjustment flows back into our continual improvement record, benefiting every batch shipped later.
We’ve seen that subtle differences in impurity profile and shelf-life can turn a promising reaction sequence into a purification headache. Reports from long-term users suggest that our approach—seasoned operators, detailed run logs, conservative specs—delivers reproducibility not as an afterthought, but as a baseline, minimizing their risk and cost across complex process chains. Many sourced similar materials elsewhere, only to face production stoppages from unseen side products or delayed supply after a single batch inconsistency.
Raw material purity, pricing volatility, and security of supply chain all drive decisions upstream. Feedstocks for trifluoromethylation bring their own headaches—volatile pricing, end-market swings, and occasional import restrictions. We mitigate these challenges with advanced purchasing agreements, yet keep a buffer stock to guard against unexpected shortfalls. Over the years, we’ve learned that supplier certification is only as reliable as their last COA: we confirm all key inputs with our own incoming analysis, routinely sending questionable shipments back rather than risk them causing out-of-spec material further downstream.
This buffer strategy has helped us weather supply disruptions when market spikes sent rival producers scrambling. Customers relying on our output could keep R&D or production lines moving, sidestepping the panic that comes when single-source materials run dry. This preparedness isn’t a luxury; it’s a necessity for those who understand the ripple effect from one missed delivery.
Demands for higher purity and scalability keep rising. Pharmaceutical developers increasing batch size expect us to deliver kilogram-scale lots at the same purity and physical consistency seen at the bench, no matter that filtration, drying, and packing act very differently at metric ton levels than in flasks. Process engineers model scale-up with our data, betting on reproducibility. Meeting their needs means rigorously mapping all process variables—solvent charge order, temperature gradients, agitation speeds—far deeper than what a spec sheet reveals.
Pressure for green chemistry alternatives continues to intensify. While Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate requires the use of halogenated materials and fluorinated reagents, we invest significantly in sourcing lower-impact raw materials and optimizing energy balance across our operations. Our solvent recovery systems have already reduced annual solvent incineration weight, and we continue to explore biobased process modifications when compatible with product quality. While not every customer demands these efforts, most recognize sustainability as a necessity rather than an optional improvement.
Each drum, each batch, each partnership is built from on-the-floor know-how, conscious attention to detail, and a willingness to tackle unpopular, time-consuming troubleshooting. Where others might gloss over production headaches or cut corners to maximize throughput, we take every deviation report seriously, tracking records as closely as any regulatory authority. This results in a product ready for the complex chemistries and evolving standards demanded by today’s fine chemical and pharmaceutical development sectors.
Those looking for a reliable supply of Ethyl 4-Chloro-2-(Trifluoromethyl)Pyrimidine-5-Carboxylate aren’t just searching for a chemical. They’re seeking a partner who understands the pressures of scale, the nuances of synthesis, and the imperatives of traceability and performance. Our history as a direct producer, not a middleman or speculator, stands behind every shipment—a record of listening, learning, and improving batch by batch, process by process.